March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Moxifloxacin Superior To Cefuroxime In Reducing Early-phase Adherence Of Staphylococcus Epidermidis To Hydrophobic Intraocular Lenses
Author Affiliations & Notes
  • Fathalah BENBOUZID
    Ophthalmology, Lyon Croix-Rousse Hospital, Lyon, France
  • Stephanie A. BAILLIF
    Ophthalmology, Saint Roch Hospital, Nice, France
  • François RENAUD
    Microbiology laboratory,
    Claude Bernard University, Lyon I, Lyon, France
  • Daniel HARTMANN
    Department of biomaterials and biological interactions,
    Claude Bernard University, Lyon I, Lyon, France
  • Philippe DENIS
    Ophthalmology, Lyon Croix-Rousse Hospital, Lyon, France
  • Laurent KODJIKIAN
    Ophthalmology, Lyon Croix-Rousse Hospital, Lyon, France
  • Footnotes
    Commercial Relationships  Fathalah Benbouzid, None; Stephanie A. Baillif, None; François Renaud, None; Daniel Hartmann, None; Philippe Denis, None; Laurent Kodjikian, None
  • Footnotes
    Support  IOLs were kindly provided by Alcon Laboratories
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6199. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Fathalah BENBOUZID, Stephanie A. BAILLIF, François RENAUD, Daniel HARTMANN, Philippe DENIS, Laurent KODJIKIAN; Moxifloxacin Superior To Cefuroxime In Reducing Early-phase Adherence Of Staphylococcus Epidermidis To Hydrophobic Intraocular Lenses. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6199. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate and compare the bacterial anti-adhesive effect of cefuroxime and moxifloxacin on the primary-attachment phase of Staphylococcus epidermidis to hydrophobic acrylic intraocular lenses (IOLs).

Methods: : Forty single-piece Acrysof IOLs (SA30AT, Alcon Surgical) were used throughout the study. IOLs were divided into 5 groups. Two groups were soaked 15 minutes in an antibiotic solution (Mox: moxifloxacin 0.5mg/0.1ml or Cef: cefuroxime 1mg/0.1ml), before incubation for 1 hour in a S epidermidis bacterial suspension which concentration was adjusted to 108 CFU/ml (N890074, Staphylococci National reference Centre, Lyon, France), (t1). Two other groups were incubated in a similar S epidermidis suspension for 15 minutes before adding cefuroxime or Moxifloxacin (t2). Incubation for these groups lasted 1 hour. The last group consisted in a control group with IOLs incubated 1 hour in the S epidermidis bacterial suspension. After incubation, IOLs were removed from the vial test and rinsed in a sterile phosphate-buffered solution before being sonicated and vortexed to remove all the adhering bacteria. The resultant suspension was diluted and spread over a nutritive agar plate. Colonies were counted after 24-hour incubation. Comparison among groups was performed using the Wald parametric statistical test. A p-value < 0.05 was considered statistically significant.

Results: : Mean numbers of CFU per IOL was Cef-t1: 184 x103[SE: 5,24 ; SD: 28,21], Cef-t2: 117 x103[SE: 5,74 ; SD: 30,37], Mox-t1: 1,27x103[SE: 0,12 ; SD: 0,61], Mox-t2: 25 x103[SE:1,98 ; SD: 9,72] and Ctrl : 361 x103[SE: 26,9 ; SD: 107,6]. The number of adhering bacteria did not vary whether cefuroxime was added before or after IOLs incubation in the bacterial suspension (p = 0.132). Moxifloxacin was more effective in reducing the number of adhering bacteria when used before IOLs incubation (p < 0.001). Overall for t1 and t2, moxifloxacin was more effective than cefuroxime (p < 0,001).

Conclusions: : The use of moxifloxacin and cefuroxime significantly reduced S.epidermidis adherence on hydrophobic acrylic IOLs. The anti-adhesive effect was superior with moxifloxacine. Further studies are needed to confirm these results on IOLs made of other biomaterials.

Keywords: endophthalmitis • intraocular lens • Staphylococcus 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.